<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39413816</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1758-1095</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Journal of the Royal Society of Medicine</Title><ISOAbbreviation>J R Soc Med</ISOAbbreviation></Journal><ArticleTitle>COVID-19-related morbidity and mortality in people with multiple long-term conditions: a systematic review and meta-analysis of over 4 million people.</ArticleTitle><Pagination><StartPage>1410768241261507</StartPage><MedlinePgn>1410768241261507</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/01410768241261507</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To describe the direct impact of coronavirus disease 2019 (COVID-19) infection on morbidity and mortality in people with multiple long-term conditions (MLTCs).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A systematic review and meta-analysis including observational studies.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Studies conducted between 1 January 2020 and 4 May 2023 across 51 countries were identified from five databases.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">A total of 4,084,469 patients with confirmed COVID-19 infection.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Pooled risk ratios (RRs) for mortality, hospitalisation, severe disease, intensive care unit (ICU) admission and mechanical ventilation were estimated with random effect meta-analysis models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 38,356 studies were identified and 111 included. In most (74%) of the studies, MLTCs referred to having two or more long-term conditions. Others described MLTCs by high weighted indices: the Charlson Comorbidity Index in 11% and the Clinical Frailty Score in 7%. Using the National Institutes of Health quality assessment tool for observational studies, the risk of bias was judged as low and moderate in 86 and 25 studies, respectively. Having MLTCs was associated with increased mortality (RR: 2.61 [95% CI: 2.27 to 3.0]); hospitalisation (2.4 [1.92 to 2.99]); severe disease (2.61 [1.92 to 3.54]); ICU admission (1.22 [1.07 to 1.39]) and mechanical ventilation (1.83 [1.18 to 2.84]) compared with those with no MLTCs. Pooled RRs for adverse outcomes were higher in children and young people compared with all age groups. In meta-regression analyses, men were more likely to need ICU admission (<i>p</i> = 0.013) and mechanical ventilation (<i>p</i> = 0.002).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Public health policies, clinical and preventative interventions should prioritise people with MLTCs to minimise direct adverse outcomes from COVID-19 disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salisu-Olatunji</LastName><ForeName>Shukrat O</ForeName><Initials>SO</Initials><Identifier Source="ORCID">0000-0002-5789-8523</Identifier><AffiliationInfo><Affiliation>Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diabetes Research Centre, Leicester General Hospital, Department of Population Health Sciences, University of Leicester, Leicester, LE1 7RH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chudasama</LastName><ForeName>Yogini V</ForeName><Initials>YV</Initials><AffiliationInfo><Affiliation>Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Navjot</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kayani</LastName><ForeName>Zara</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0009-0009-1201-6994</Identifier><AffiliationInfo><Affiliation>Diabetes Research Centre, Leicester General Hospital, Department of Population Health Sciences, University of Leicester, Leicester, LE1 7RH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odugbemi</LastName><ForeName>Babatunde A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Community Health and Primary Health Care, Lagos State University College of Medicine (LASUCOM), Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Health and Primary Health Care, Lagos State University Teaching Hospital (LASUTH), Ikeja, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolodeoku</LastName><ForeName>Olasope Esther</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Department of Community Health and Primary Health Care, Lagos State University Teaching Hospital (LASUTH), Ikeja, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konnor</LastName><ForeName>Shirley Akua</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vounzoulaki</LastName><ForeName>Elpida</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharjee</LastName><ForeName>Atanu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Population Health and Genomics, Medical School, University of Dundee, Scotland, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fahami</LastName><ForeName>Radia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Diabetes Research Centre, Leicester General Hospital, Department of Population Health Sciences, University of Leicester, Leicester, LE1 7RH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valabhji</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9756-4061</Identifier><AffiliationInfo><Affiliation>NHS England and Improvement, Skipton House, London, SW1A 0AA, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Metabolism, Digestion and Reproduction, Imperial College London, London, W12 0NN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8741-3411</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaccardi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillies</LastName><ForeName>Clare L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khunti</LastName><ForeName>Kamlesh</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diabetes Research Centre, Leicester General Hospital, Department of Population Health Sciences, University of Leicester, Leicester, LE1 7RH, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J R Soc Med</MedlineTA><NlmUniqueID>7802879</NlmUniqueID><ISSNLinking>0141-0768</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">infectious diseases</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>19</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39413816</ArticleId><ArticleId IdType="doi">10.1177/01410768241261507</ArticleId></ArticleIdList></PubmedData></PubmedArticle>